Search Results 91-100 of 16665 for Lormetazepam

  1. https://www.mayoclinic.org/chinese_organization_concepts.xml

  2. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  3. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  4. Clinical trials - Oncology (Medical)

    Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer. This study hopes ...

  5. A Trial to Investigate Long Term Effectiveness and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency - Mayo Clinic

    Inclusion Criteria: - Signing of the trial specific informed consent. - Completion of the treatment period and Visit 7 assessments of trial TCH-306, ...

  6. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

    Cabozantinib-s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

  7. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...

  8. Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer - Mayo Clinic

    This pilot, phase II trial studies how well everolimus and letrozole work in treating patients with hormone receptor positive ovarian, fallopian tube, or ...

  9. Drugs and Supplements that Start with Y - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “Y” to learn about drug side effects, proper use and ...

  10. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments - Mayo Clinic

    This phase 1b trial is an open-label study designed to assess the safety, tolerability, and preliminary antitumor activity of REGN5458 in combination with other ...